Ajinomoto's Earthquake Response At Fukushima: A Business Continuity Case Study
This article was originally published in PharmAsia News
Shinji Oshiguchi, the plant manager for Ajinomoto's Fukushima production plant, outlines the precautionary steps, response, and restarting protocols during a natural disaster.
You may also be interested in...
Business Continuity Vital In Japan For Companies Like Daiichi Sankyo On Slow Road To Recovery; Earthquake Impacts Organizational Moves
TOKYO - An emerging view of the damage to pharmaceutical companies in Japan points to a scenario in which affected companies must find a way to ensure business continuity while simultaneously beginning a slow recovery
Southwest Japan-heavy Takeda And Dainippon Sumitomo Spared Earthquake Damage, Others May Rebound, But Tokyo Headquarters' Quieted By Rail Disruptions
TOKYO - Offices across Tokyo remained closed Tuesday, stalling the operations of headquarters for many pharma and medical device companies in Japan as the city faced train and highway closures and threats of blackouts through the rest of the week. Meanwhile, stocks for many of the Japanese pharma tumbled on the Nikkei March 14 in response to the emergency at power plants in Fukushima prefecture
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?